Form 4: Charles River Labs Director Trades Shares
Insider Transaction Report
Nancy C. Andrews, a Director at Charles River Laboratories International, Inc., reported a transaction involving the acquisition of common stock.
Summary
- Nancy C. Andrews, a Director at Charles River Laboratories International, Inc. (CRL), reported a transaction on May 8, 2026.
- The transaction involved the acquisition of 1,438 shares of common stock at a price of $177.62 per share.
- Following this transaction, Ms. Andrews beneficially owns 5,402 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine disclosure of a director's stock transaction without immediate strong indicators of significant positive or negative company performance.
Positives
- Director Nancy C. Andrews acquired additional shares, indicating potential confidence in the company's future.
- The acquisition was made at a specific price point, suggesting a planned investment rather than a market opportunistic purchase.
Future Outlook
The filing mentions that unvested restricted stock units vest upon the earlier of May 8, 2027, or the business day prior to the Company's next annual meeting of shareholders.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the buying and selling activities of company directors and officers. Such transactions can sometimes signal insider sentiment regarding the company's valuation and prospects.
Stakeholder Impact
- Shareholders: The transaction provides transparency into insider activity, which can influence investor perception.
- Management: The acquisition by a director may be interpreted as a sign of confidence in the company's strategy and future performance.
Next Steps
- Vesting of unvested restricted stock units on May 8, 2027, or the business day prior to the Company's next annual meeting of shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/08/2026 | Transaction Date for acquisition of common stock. |
| 05/11/2026 | Date of Report/Signature. |
| 05/08/2027 | Vesting date for unvested restricted stock units (earlier of this date or day before next annual meeting). |
Keywords
Form 4, SEC Filing, Insider Trading, Charles River Laboratories, Nancy C. Andrews, Common Stock, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.